Skip to content

Safety and Feasibility of Liver Retraction With the Levita Magnetic Surgical System: Extended Magnetic Grasper Device

Prospective, Multi-center, Single-arm, Open Label Study Designed to Assess the Safety and Feasibility of Liver Retraction With the Levita Magnetic Surgical System: Extended Magnetic Grasper Device

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06432088
Enrollment
30
Registered
2024-05-29
Start date
2024-05-13
Completion date
2024-09-30
Last updated
2025-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bariatric Surgery Candidate, Hiatal Hernia

Brief summary

The purpose of this study is to evaluate the safety and effectiveness of the Extended Magnetic Grasper Device in patients undergoing bariatric and/or hiatal hernia procedures, as a liver retractor grasping the liver and/or the tissue surrounding the crus of the diaphragm.

Detailed description

The purpose of this study is to evaluate the safety and effectiveness of the Levita Magnetic Surgical System Version 2 in patients undergoing bariatric and/or hiatal hernia procedures.

Interventions

DEVICEExtended Magnetic Grasper Device

The purpose of this study is to evaluate the safety and effectiveness of the Extended Magnetic Grasper Device in patients undergoing bariatric and/or hiatal hernia procedures, as a liver retractor grasping the liver and/or the tissue surrounding the crus of the diaphragm.

Sponsors

Levita Magnetics
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* At least 18 years of age. * Scheduled to undergo elective bariatric and/or hiatal hernia procedures. * Willing and able to provide a written Informed Consent Form (ICF) to participate in the study prior to any study required procedures.

Exclusion criteria

* Individuals with pacemakers, defibrillators, or other electromedical implants. * Individuals with ferromagnetic implants. * American Society of Anesthesiologists (ASA) score of III or IV. * Significant comorbidities: cardiovascular, neuromuscular, chronic obstructive pulmonary disease, and urological disease (renal failure). * Clinical history of impaired coagulation confirmed by abnormal blood tests. * Individuals has signs of hepatic abnormality (e.g.: cirrhosis, liver failure, increase in liver enzymes, etc.). * Anatomical abnormality or disease of intended target tissue noted after initiation of index procedure that would prevent device use. * Pregnant or wishes to become pregnant during the length of study participation. * Individual is not likely to comply with the follow-up evaluation schedule. * Participating in a clinical trial of another investigational drug or device. * Prisoner or under incarceration.

Design outcomes

Primary

MeasureTime frameDescription
Number of Device Related Adverse Events30 daysAll adverse events will be captured and reported. Adverse events will be summarized by relatedness to the device and/or procedure, seriousness and level of severity.
Mobilization Requiring Additional Retractors1 dayAbility to adequately mobilize the liver to achieve an effective exposure of the target tissue. Adequate mobilization is not achieved if it is necessary to use another liver retractor during the procedure.

Countries

Chile

Participant flow

Participants by arm

ArmCount
Extended Magnetic Grasper Device
Evaluation of the safety and effectiveness of the Extended Magnetic Grasper Device in patients undergoing bariatric and/or hiatal hernia procedures, as a liver retractor grasping the liver and/or the tissue surrounding the crus of the diaphragm. Extended Magnetic Grasper Device: The purpose of this study is to evaluate the safety and effectiveness of the Extended Magnetic Grasper Device in patients undergoing bariatric and/or hiatal hernia procedures, as a liver retractor grasping the liver and/or the tissue surrounding the crus of the diaphragm.
30
Total30

Baseline characteristics

CharacteristicExtended Magnetic Grasper Device
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
2 Participants
Age, Categorical
Between 18 and 65 years
28 Participants
BMI39.09 kg/m²
STANDARD_DEVIATION 5.46
Ethnicity (NIH/OMB)
Hispanic or Latino
30 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Region of Enrollment
Chile
30 participants
Sex: Female, Male
Female
22 Participants
Sex: Female, Male
Male
8 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 30
other
Total, other adverse events
14 / 30
serious
Total, serious adverse events
0 / 30

Outcome results

Primary

Mobilization Requiring Additional Retractors

Ability to adequately mobilize the liver to achieve an effective exposure of the target tissue. Adequate mobilization is not achieved if it is necessary to use another liver retractor during the procedure.

Time frame: 1 day

ArmMeasureValue (NUMBER)
Extended Magnetic Grasper DeviceMobilization Requiring Additional Retractors0 Procedures w/ additional retractors
Primary

Number of Device Related Adverse Events

All adverse events will be captured and reported. Adverse events will be summarized by relatedness to the device and/or procedure, seriousness and level of severity.

Time frame: 30 days

ArmMeasureValue (NUMBER)
Extended Magnetic Grasper DeviceNumber of Device Related Adverse Events0 Device related adverse events

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026